Custom crystal celebrating a commercial rights agreement between pharmaceutical firm Zogenix and Nippon Shinyaku. Zogenix focuses on rare disease therapies.
(9ALj481)
Custom crystal celebrating a commercial rights agreement between pharmaceutical firm Zogenix and Nippon Shinyaku. Zogenix focuses on rare disease therapies.
(9ALj481)Custom crystal commemorating an exclusive distribution agreement between California-based pharmaceutical firm Zogenix and Japanese pharma company Nippon Shinyaku.
(9ALJ481)Custom crystal tombstone commemorating clinical trial financing provided for biopharmaceutical company, Clovis Oncology. The clinical trial sponsored by Clovis involves an ovarian cancer study.
(9ALJ233)Custom Lucite, with an embedded champagne cork, celebrating the approval by the Food and Drug Administration (FDA) of the obesity treatment Plenity. Plenity was developed by Boston-based biotech firm Gelesis.
(9AMF149)Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders.
(8ALJ498)Custom employee recognition award presented by biopharmaceutical firm Gilead Sciences.
Sales Excellence Award presented by AstraZeneca. AstraZeneca is a multinational pharmaceutical firm headquartered in London.
Launch recognition product commemorating a the first in human study by Catabasis Pharmaceuticals, based in Cambridge, MA
